Oxcarbazepine adjunctive therapy in infants and young children with partial seizures
Authors:
- J. E. Piña-GarzaJPJ. E. Piña-Garza
- R. EspinozaRER. Espinoza
- D. NordliDND. Nordli
- D. A. BennettDBD. A. Bennett
- S. SpiritoSSS. Spirito
- T. E. StitesTST. E. Stites
- D. TangDTD. Tang
- Y. SturmYSY. Sturm
- 8 November 2005
- journal article
- research article
- Published by Wolters Kluwer Health in Neurology
- Vol. 65 (9) , 1370-1375
Abstract
Objective: To evaluate the efficacy, safety, and pharmacokinetics of oxcarbazepine as adjunctive therapy in infants and young children (1 month to p = 0.043). The median percentage reduction in type 1 seizure frequency per 24 hours was also greater in the high-dose group (83.33%) than in the low-dose group (46.18%; p = 0.047). The most frequent adverse events (≥10%) were somnolence and pyrexia, and most were mild in severity. Conclusions: In this study, high-dose oxcarbazepine was significantly more effective than low-dose oxcarbazepine in controlling partial seizures in infants and very young children.Keywords
This publication has 9 references indexed in Scilit:
- Oxcarbazepine Pharmacokinetics and Tolerability in Children With Inadequately Controlled EpilepsyThe Journal of Clinical Pharmacology, 2004
- OxcarbazepinePediatric Drugs, 2003
- Oxcarbazepine (Trileptal) as monotherapy in patients with partial seizuresNeurology, 2001
- Oxcarbazepine Placebo‐Controlled, Dose‐Ranging Trial in Refractory Partial EpilepsyEpilepsia, 2000
- Oxcarbazepine monotherapy for partial-onset seizuresNeurology, 2000
- Adjunctive therapy with oxcarbazepine in children with partial seizuresNeurology, 2000
- Managing Pediatric Epilepsy Syndromes With New Antiepileptic DrugsPediatrics, 1999
- A double-blind controlled clinical trial of oxcarbazepine versus phenytoin in children and adolescents with epilepsyEpilepsy Research, 1997
- Proposal for Revised Clinical and Electroencephalographic Classification of Epileptic SeizuresEpilepsia, 1981